CD4 and neoplasm: He et al. [158] reported similar results: tumour-infiltrating immune cells vary depending on risk scores and the proportions of CD8+ T cells, activated memory CD4+ as well as T follicular helper cells, all of which are significantly higher in the low-risk group with a better prognosis [158].